Sign In
Buy PYPD
$4.29
-0.0800 (-1.83%)
At Close: Jul 31, 2026
PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023
07:00am, Monday, 09'th Oct 2023
PETACH TIKVA, Israel, Oct. 09, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today an
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
07:00am, Wednesday, 04'th Oct 2023
Safety Profile of D-PLEX 100 and PLEX Platform Shown in Juvenile Animals for the First Time
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
07:00am, Friday, 22'nd Sep 2023
PETACH TIKVA, Israel, Sept. 22, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today
PolyPid Ltd (PYPD) Q2 2023 Earnings Call Transcript
12:55pm, Wednesday, 09'th Aug 2023
PolyPid Ltd (NASDAQ:PYPD ) Q2 2023 Earnings Conference Call August 9, 2023 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Dikla Akselbrad - CEO & Director Jonny Missulawin - CFO Ori
PolyPid to Participate in Upcoming Investor Conferences
07:00am, Monday, 24'th Apr 2023
PETACH TIKVA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today a
PolyPid Ltd (PYPD) Q4 2022 Earnings Call Transcript
01:20pm, Wednesday, 08'th Feb 2023
PolyPid Ltd (NASDAQ:PYPD ) Q4 2022 Earnings Conference Call February 8, 2023 8:30 AM ET Company Participants Brian Ritchie - LifeSci Advisors Dikla Akselbrad - CEO Ori Warshavsky - COO, US Jonny Missu
PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023
07:00am, Tuesday, 31'st Jan 2023
PETACH TIKVA, Israel, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today an
7 Top Penny Stocks Under $1 To Watch Before Next Week
12:16pm, Thursday, 26'th Jan 2023
Penny stocks under $1 to watch right now. The post 7 Top Penny Stocks Under $1 To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks To Buy? 4 Under $1 To Watch In January 2023
09:00am, Tuesday, 24'th Jan 2023
Are these penny stocks under $1 on your watch list this week? The post Best Penny Stocks To Buy?
PolyPid Ltd. (PYPD) Q3 2022 Earnings Call Transcript
03:29pm, Saturday, 12'th Nov 2022
PolyPid Ltd. (NASDAQ:PYPD ) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Dikla Czaczkes Akselbrad - Chief Executiv
PolyPid to Report Third Quarter 2022 Financial Results and Operational Highlights on November 9, 2022
07:00am, Wednesday, 26'th Oct 2022
PETACH TIKVA, Israel, Oct. 26, 2022 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today ann
Best Penny Stocks To Buy Now? 3 To Watch As Stock Market Crash Continues
11:46am, Thursday, 29'th Sep 2022
Biotech penny stocks to watch as stock market crash continues today. The post Best Penny Stocks To Buy Now?
Wall Street Analysts Think PolyPid Ltd. (PYPD) Could Surge 206%: Read This Before Placing a Bet
11:17am, Wednesday, 31'st Aug 2022
The mean of analysts' price targets for PolyPid Ltd. (PYPD) points to a 205.6% upside in the stock.
All You Need to Know About PolyPid Ltd. (PYPD) Rating Upgrade to Buy
01:32pm, Monday, 15'th Aug 2022
PolyPid Ltd. (PYPD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
PolyPid Ltd. (PYPD) CEO Dikla Czaczkes Akselbrad on Q2 2022 Results - Earnings Call Transcript
09:51pm, Wednesday, 10'th Aug 2022
PolyPid Ltd. (NASDAQ:PYPD ) Q2 2022 Results Conference Call August 10, 2022 8:30 AM ET Company Participants Bob Yedid - IR, LifeSci Advisors Dikla Czaczkes Akselbrad - CEO Ori Warshavsky - COO, U.S. O
